Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Henson

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Neurology|April 2, 2021
Prospective Quantification of CSF Biomarkers in Antibody-Mediated EncephalitisGregory S Day, Melanie Y Yarbrough, Peter Körtvelyessy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Neurology. Genetics|April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic VariantsSuzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Neurology|November 4, 2024
Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer DiseaseMichelle Safransky, Jenna R Groh, Kaj Blennow, et al.
Nature Medicine|February 21, 2024
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Gemma Salvadó, Suzanne E Schindler, et al.
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Histology and Histopathology|June 10, 2005
Karyotypic analysis of adult pluripotent stem cellsN L Henson, M L Heaton, B H Holland, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2022
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based ApproachJigyasha Timsina, Duber Gomez-Fonseca, Lihua Wang, et al.
Neurology|April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament LightSuzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Neurology|April 2, 2021
Prospective Quantification of CSF Biomarkers in Antibody-Mediated EncephalitisGregory S Day, Melanie Y Yarbrough, Peter Körtvelyessy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Neurology. Genetics|April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic VariantsSuzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Neurology|November 4, 2024
Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer DiseaseMichelle Safransky, Jenna R Groh, Kaj Blennow, et al.
Nature Medicine|February 21, 2024
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Gemma Salvadó, Suzanne E Schindler, et al.
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Histology and Histopathology|June 10, 2005
Karyotypic analysis of adult pluripotent stem cellsN L Henson, M L Heaton, B H Holland, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2022
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based ApproachJigyasha Timsina, Duber Gomez-Fonseca, Lihua Wang, et al.
Neurology|April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament LightSuzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Pageof 8